What is CHNXF stock price today?

CHNXF (ChitogenX Inc.) stock is trading at $0.01 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CHNXF stock going up or down today?

CHNXF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CHNXF stock now?

The decision to buy CHNXF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CHNXF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CHNXF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CHNXF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CHNXF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CHNXF's P/E ratio?

P/E ratio data for CHNXF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CHNXF's market cap?

CHNXF (ChitogenX Inc.) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is CHNXF's price to book ratio?

Price-to-book ratio for CHNXF is available on our dashboard along with other valuation metrics.

Does CHNXF pay dividends?

CHNXF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CHNXF's dividend yield?

CHNXF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CHNXF stock a good long-term investment?

CHNXF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CHNXF's revenue growth rate?

Revenue growth data for CHNXF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CHNXF are available on our dashboard with complete income statement analysis.

What are the risks of investing in CHNXF?

Key risks for CHNXF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CHNXF compare to its competitors?

Compare CHNXF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CHNXF's performance and positioning.

What is CHNXF's stock price target for 2026?

Our AI model provides price targets for CHNXF based on fundamental analysis: Bull case $0.01 (+30%), Base case $0.01 (+15%), Bear case $0.01 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CHNXF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CHNXF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CHNXF's next earnings report?

CHNXF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CHNXF - ChitogenX Inc.

NYSE * Healthcare * Biotechnology

$0.01

+$0.00 (+0.00%)

About ChitogenX Inc.

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.

CHNXF Key Statistics

Market Cap

$0.63M

EPS

$-0.01

How CHNXF Compares to Peers

CHNXF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CHNXF(This stock)	$627.63K	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.34B	24.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$171.97B	20.4	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$110.81B	28.4	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.87B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.03B	20.0	-0%	0.1%	vs BIIB

ChitogenX Inc. Company Information

Headquarters: 16667 Hymus Boulevard, Kirkland, QC, Canada, H9H 4R9, undefined
Website: www.chitogenx.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 18, 2026 at 9:05 AM EDT

Ready to invest in CHNXF?

Commission-free trading available. Affiliate links.

Upcoming Events for CHNXF

Dashboard

Enter a ticker to analyze